Gyre Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GYRE and other ETFs, options, and stocks.About GYRE
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis).
CEOPing Zhang
CEOPing Zhang
Employees5
Employees5
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1997
Founded1997
Employees5
Employees5
GYRE Key Statistics
Market cap747.55M
Market cap747.55M
Price-Earnings ratio198.95
Price-Earnings ratio198.95
Dividend yield—
Dividend yield—
Average volume47.85K
Average volume47.85K
High today$7.77
High today$7.77
Low today$7.50
Low today$7.50
Open price$7.64
Open price$7.64
Volume27.90K
Volume27.90K
52 Week high$14.42
52 Week high$14.42
52 Week low$6.11
52 Week low$6.11
Stock Snapshot
Gyre Therapeutics(GYRE) stock is priced at $7.76, giving the company a market capitalization of 747.55M. It carries a P/E multiple of 198.95.
On 2025-12-04, Gyre Therapeutics(GYRE) stock traded between a low of $7.50 and a high of $7.77. Shares are currently priced at $7.76, which is +3.5% above the low and -0.1% below the high.
The Gyre Therapeutics(GYRE)'s current trading volume is 27.9K, compared to an average daily volume of 47.85K.
During the past year, Gyre Therapeutics(GYRE) stock moved between $6.11 at its lowest and $14.42 at its peak.
During the past year, Gyre Therapeutics(GYRE) stock moved between $6.11 at its lowest and $14.42 at its peak.
People also own
Based on the portfolios of people who own GYRE. This list is generated using Robinhood data, and it’s not a recommendation.